As of late May 2026, the CDC reported 1,983 confirmed U.S. measles cases year-to-date through May 28, with 93% linked to ongoing outbreaks and 92% occurring among unvaccinated individuals or those with unknown status. This surge, building on 2,288 cases in 2025, stems from sustained transmission in under-vaccinated communities across multiple states, including rising activity in Utah after earlier peaks in Texas and South Carolina. Official surveillance shows most cases are domestically acquired rather than travel-related, heightening risks to the nation’s measles elimination status declared in 2000. Upcoming CDC updates on case counts and outbreak status through the end of May will provide final data for resolution, while summer travel patterns could influence any late additions.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoMeasles cases in U.S. by May 31?
Measles cases in U.S. by May 31?
$196,980 Wol.
May 31, 2026
1800
Yes
1900
Yes
1925
Yes
1950
Yes
2000
No
2200
No
2400
No
$196,980 Wol.
1800
$4,781 Wol.
Yes
1900
$39,649 Wol.
Yes
1925
$9,810 Wol.
Yes
1950
$24,533 Wol.
Yes
2000
$86,567 Wol.
No
2200
$23,708 Wol.
No
2400
$7,931 Wol.
No
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of late May 2026, the CDC reported 1,983 confirmed U.S. measles cases year-to-date through May 28, with 93% linked to ongoing outbreaks and 92% occurring among unvaccinated individuals or those with unknown status. This surge, building on 2,288 cases in 2025, stems from sustained transmission in under-vaccinated communities across multiple states, including rising activity in Utah after earlier peaks in Texas and South Carolina. Official surveillance shows most cases are domestically acquired rather than travel-related, heightening risks to the nation’s measles elimination status declared in 2000. Upcoming CDC updates on case counts and outbreak status through the end of May will provide final data for resolution, while summer travel patterns could influence any late additions.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Rynek otwarty: Apr 28, 2026, 6:09 PM ET
Wolumen
$196,980Data zakończenia
May 31, 2026Rynek otwarty
Apr 28, 2026, 6:09 PM ETResolver
0x65070BE91...Wynik zaproponowany: Yes
Brak sporu
Ostateczny wynik: Yes
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of late May 2026, the CDC reported 1,983 confirmed U.S. measles cases year-to-date through May 28, with 93% linked to ongoing outbreaks and 92% occurring among unvaccinated individuals or those with unknown status. This surge, building on 2,288 cases in 2025, stems from sustained transmission in under-vaccinated communities across multiple states, including rising activity in Utah after earlier peaks in Texas and South Carolina. Official surveillance shows most cases are domestically acquired rather than travel-related, heightening risks to the nation’s measles elimination status declared in 2000. Upcoming CDC updates on case counts and outbreak status through the end of May will provide final data for resolution, while summer travel patterns could influence any late additions.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Wolumen
$196,980Data zakończenia
May 31, 2026Rynek otwarty
Apr 28, 2026, 6:09 PM ETResolver
0x65070BE91...Wynik zaproponowany: Yes
Brak sporu
Ostateczny wynik: Yes
As of late May 2026, the CDC reported 1,983 confirmed U.S. measles cases year-to-date through May 28, with 93% linked to ongoing outbreaks and 92% occurring among unvaccinated individuals or those with unknown status. This surge, building on 2,288 cases in 2025, stems from sustained transmission in under-vaccinated communities across multiple states, including rising activity in Utah after earlier peaks in Texas and South Carolina. Official surveillance shows most cases are domestically acquired rather than travel-related, heightening risks to the nation’s measles elimination status declared in 2000. Upcoming CDC updates on case counts and outbreak status through the end of May will provide final data for resolution, while summer travel patterns could influence any late additions.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania